Senti Biosciences CFO Resigns, Transitions to Consultancy Role

An update from Senti Biosciences (SNTI) is now available.

Deborah Knobelman, Ph.D., has decided to step down as CFO, Treasurer, and Head of Corporate Development at Senti Biosciences, effective May 3, 2024. Her resignation is not due to any dispute with the company’s practices. Following her departure, she’ll transition to a consultancy role to assist with a smooth handover of her duties, for which she’ll receive up to $60,000. Meanwhile, Senti Biosciences is actively seeking an interim CFO and Treasurer to fill the vacancy.

For an in-depth examination of SNTI stock, go to TipRanks’ Stock Analysis page.